3SOF

IMNR is building some volume over the past 3 sessions.
The stock is heavily depressed, been downgraded to the OTC market sometime ago, and it's probably not a «serious» company. Enough said, anything going on here would be pure speculation...

This stock was already discussed on our free boards, they are into the HIV drugs:
Profile: The Immune Response Corporation, an immuno-pharmaceutical company, focuses on the development of various products to treat autoimmune and infectious diseases. It offers NeuroVax, which is based on T-cell receptor peptide technology for the treatment of multiple sclerosis; and IR103 and Remune for the treatment of Human Immunodeficiency Virus (HIV). These products are in Phase II clinical trails. The Immune Response Corporation was founded by Jonas Salk in 1986 and is headquartered in Carlsbad, California.
Website: http://www.imnr.com
Market Cap: 6.30M (not sure if this is accurate, as they are constantly diluting their float).


This stock showed up on my filters last Thursday, and keep showing up since then I'm not sure why... So the best I can do it's to post it here just in case some wild speculation is about to happen Are they just about to discover the cure for AIDS? and their CEO receiving the Nobel prize ? well, probably nothing...

Regards,

I've been watching this also, Rams.  Investors have been exercising options like crazy for around .02/share.  I haven't bought since I don't know if this is a good thing or bad. 

Insiders have been buying for some time and at MUCH higher prices.  Seems like something could be up but this option stuff will also dilute the share base quite a bit.  Any comments?